Wednesday, 18 Jul 2018

You are here

Leflunomide May Sensitize the Insulin Receptor and Have an Anti-Glycemic Effect

An animal model study in the Journal of Endocrinololgy reports the potential use of leflunomide in the control of hyperglycemia in male mice. (Citation source https://buff.ly/2te3GpP)

Hyperactivation (serine/threonine kinase that phosphorylates the insulin receptor substrate-1) of S6K1 due to overnutrition leads to hyperglycemia and type 2 diabetes in mice.

Investigators have shown that A77 1726 (active metabolite of leflunomide) is an inhibitor of S6K1 and tested if leflunomide can control hyperglycemia and sensitize the insulin receptor.

They tested leflunomide on ob/ob and high-fat diet (HFD)-induced diabetes mice and found leflunomide normalized blood glucose levels and overcame insulin resistance ob/ob and HFD-fed mice but had no effect on mice fed a normal chow diet (NCD).

They believe  that leflunomide sensitizes the insulin receptor by inhibiting S6K1 activity and could be potentially useful for treating patients with both RA and diabetes.

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Predictors of Methotrexate Non-Response

New research from a UK study suggests that nonresponse to oral or subcutaneous MTX was seen in 43% and is predicted by seronegativity, higher disease activity measures and higher anxiety scores.

Best of 2017: New EULAR Guidelines on Behçet's

At the EULAR 2016 meeting, new EULAR recommendations for the management of Behçet's disease (BD) were presented. These were developed by a multidisciplinary expert committee that reviewed the evidence from the medical literature and developed final set of 9 recommendations:

EULAR 2018 - Day 3 Report

Day 3 highlights include Behcet’s responds to apremilast and that biologics do not differentially affect TKR/THR post-operative infection rates. Be sure to check out today's podcast as well. 

Canada Closer to Marijuana Approval

Reuters reports that Canada’s Senate on Thursday voted to legalize recreational marijuana, clearing a major hurdle that puts the country on track to become the first Group of Seven nation to permit national use of the drug.

Now the law and amendments go to the House of Commons who will need to decide on before the law can be passed.

Advance Practice Clinicians Proliferating in Specialty Practices

An analysis of SK&A outpatient provider files, covering 90% of physician practices in the United States, shows that between 2008 to 2016, there was a 22% increase in the employment of advanced practice clinicians (APCs) by specialty practices.  By 2016, 28% of all specialty practices employed APCs.